TCT 3: Ticagrelor Monotherapy After Coronary Stenting in Patients With Acute Myocardial Infarction (TIMO-AMI Study)
We Recommend
Disclosures
Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients:
- Consultant Fee/Honoraria/Speaker’s Bureau - Abbott; Boston Scientific Corporation
- Consultant Fee/Honoraria/Speaker's Bureau - Medtronic
- Grant Support/Research Contract - AstraZenca; Abbott